193 related articles for article (PubMed ID: 7286579)
1. Furosemide disposition in cirrhotic patients.
Sawhney VK; Gregory PB; Swezey SE; Blaschke TF
Gastroenterology; 1981 Dec; 81(6):1012-6. PubMed ID: 7286579
[TBL] [Abstract][Full Text] [Related]
2. Ranitidine disposition in severe hepatic cirrhosis.
Gonzalez-Martin G; Paulos C; Veloso B; Chesta J; Novoa X; Arancibia A
Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):139-42. PubMed ID: 3557740
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of cimetidine in ascitic cirrhotics].
Albin H; Couzigou P; Vinçon G; Péhourcq F; Fleury B; Béraud C
Gastroenterol Clin Biol; 1983 Mar; 7(3):251-5. PubMed ID: 6852412
[TBL] [Abstract][Full Text] [Related]
4. Furosemide kinetics in patients with hepatic cirrhosis with ascites.
Fuller R; Hoppel C; Ingalls ST
Clin Pharmacol Ther; 1981 Oct; 30(4):461-7. PubMed ID: 7285480
[TBL] [Abstract][Full Text] [Related]
5. Sufentanil pharmacokinetics in patients with cirrhosis.
Chauvin M; Ferrier C; Haberer JP; Spielvogel C; Lebrault C; Levron JC; Duvaldestin P
Anesth Analg; 1989 Jan; 68(1):1-4. PubMed ID: 2521279
[TBL] [Abstract][Full Text] [Related]
6. Temazepam clearance unaltered in cirrhosis.
Ochs HR; Greenblatt DJ; Verburg-Ochs B; Matlis R
Am J Gastroenterol; 1986 Jan; 81(1):80-4. PubMed ID: 2867675
[TBL] [Abstract][Full Text] [Related]
7. Colchicine clearance is impaired in alcoholic cirrhosis.
Leighton JA; Bay MK; Maldonado AL; Schenker S; Speeg KV
Hepatology; 1991 Dec; 14(6):1013-5. PubMed ID: 1959847
[TBL] [Abstract][Full Text] [Related]
8. Normal metabolism of morphine in cirrhosis.
Patwardhan RV; Johnson RF; Hoyumpa A; Sheehan JJ; Desmond PV; Wilkinson GR; Branch RA; Schenker S
Gastroenterology; 1981 Dec; 81(6):1006-11. PubMed ID: 7286578
[TBL] [Abstract][Full Text] [Related]
9. Furosemide kinetics and dynamics in patients with cirrhosis.
Villeneuve JP; Verbeeck RK; Wilkinson GR; Branch RA
Clin Pharmacol Ther; 1986 Jul; 40(1):14-20. PubMed ID: 3720175
[TBL] [Abstract][Full Text] [Related]
10. Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay.
Smith DE; Lin ET; Benet LZ
Drug Metab Dispos; 1980; 8(5):337-42. PubMed ID: 6107232
[TBL] [Abstract][Full Text] [Related]
11. [Furosemide--pharmacokinetics in geriatric patients with multimorbidity].
Neubig E; Mühlberg W; Platt D
Z Gerontol; 1984; 17(5):251-60. PubMed ID: 6523981
[TBL] [Abstract][Full Text] [Related]
12. Furosemide disposition in cirrhosis.
Verbeeck RK; Patwardhan RV; Villeneuve JP; Wilkinson GR; Branch RA
Clin Pharmacol Ther; 1982 Jun; 31(6):719-25. PubMed ID: 7075120
[TBL] [Abstract][Full Text] [Related]
13. Role of binding in distribution of furosemide: where is nonrenal clearance?
Branch RA
Fed Proc; 1983 Apr; 42(6):1699-702. PubMed ID: 6832389
[TBL] [Abstract][Full Text] [Related]
14. Quinidine disposition in relation to antipyrine elimination and debrisoquine phenotype in alcoholic patients with and without cirrhosis.
Debruyne D; Gram LF; Grollier G; Camsonne R; Agron L; Dao MT; Lacotte J; Bigot MC; Moulin M
Int J Clin Pharmacol Res; 1989; 9(5):319-25. PubMed ID: 2625371
[TBL] [Abstract][Full Text] [Related]
15. Spironolactone and enzyme induction in patients with alcoholic cirrhosis.
Miguet JP; Vuitton D; Thebault-Lucas A; Joanne C; Dhumeaux D
Gastroenterology; 1980 May; 78(5 Pt 1):996-1000. PubMed ID: 7380205
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of furosemide in patients with hepatic cirrhosis.
González G; Arancibia A; Rivas MI; Caro P; Antezana C
Eur J Clin Pharmacol; 1982; 22(4):315-20. PubMed ID: 7106167
[TBL] [Abstract][Full Text] [Related]
17. Enhanced bioavailability and decreased clearance of analgesics in patients with cirrhosis.
Neal EA; Meffin PJ; Gregory PB; Blaschke TF
Gastroenterology; 1979 Jul; 77(1):96-102. PubMed ID: 447033
[TBL] [Abstract][Full Text] [Related]
18. Elimination of furosemide in healthy subjects and in those with renal failure.
Beermann B; Dalén E; Lindström B
Clin Pharmacol Ther; 1977 Jul; 22(1):70-8. PubMed ID: 872498
[TBL] [Abstract][Full Text] [Related]
19. Effect of cimetidine on the absorption and efficacy of orally administered furosemide.
Rogers HJ; Morrison P; House FR; Bradbrook ID
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):8-11. PubMed ID: 7056605
[TBL] [Abstract][Full Text] [Related]
20. Oral and intravenous pharmacokinetics of ranitidine in patients with liver cirrhosis.
Okolicsanyi L; Venuti M; Strazzabosco M; Orlando R; Nassuato G; Iemmolo RM; Lirussi F; Muraca M; Pastorino AM; Castelli G
Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):329-32. PubMed ID: 6086536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
